Search Results - "LEREN, P"

Refine Results
  1. 1

    Flavonoids regulate LDLR through different mechanisms tied to their specific structures by Bjune, Katrine, Halvorsen, Pia Skovholt, Wangensteen, Helle, Leren, Trond P., Bogsrud, Martin Prøven, Strøm, Thea Bismo

    Published in Journal of lipid research (01-05-2024)
    “…Flavonoids, polyphenolic compounds found in plant-based diets, are associated with reduced risk of cardiovascular disease and longevity. These components are…”
    Get full text
    Journal Article
  2. 2

    Functional characterization of missense variants affecting the extracellular domains of ABCA1 using a fluorescence-based assay by Teigen, Marianne, Ølnes, Åsa Schawlann, Bjune, Katrine, Leren, Trond P, Bogsrud, Martin Prøven, Strøm, Thea Bismo

    Published in Journal of lipid research (01-01-2024)
    “…Excess cholesterol originating from nonhepatic tissues is transported within HDL particles to the liver for metabolism and excretion. Cholesterol efflux is…”
    Get full text
    Journal Article
  3. 3

    Variants in the CETP gene affect levels of HDL cholesterol by reducing the amount, and not the specific lipid transfer activity, of secreted CETP by Ølnes, Åsa Schawlann, Teigen, Marianne, Laerdahl, Jon K, Leren, Trond P, Strøm, Thea Bismo, Bjune, Katrine

    Published in PloS one (01-12-2023)
    “…Background Cholesteryl ester transfer protein (CETP) transfers cholesteryl esters in plasma from high density lipoprotein (HDL) to very low density lipoprotein…”
    Get full text
    Journal Article
  4. 4

    MK-2206, an allosteric inhibitor of AKT, stimulates LDLR expression and LDL uptake: A potential hypocholesterolemic agent by Bjune, Katrine, Sundvold, Hilde, Leren, Trond P., Naderi, Soheil

    Published in Atherosclerosis (01-09-2018)
    “…Induction of low-density lipoprotein receptor (LDLR) plays a significant role in reduction of plasma LDL-cholesterol (LDL-C) levels. Therefore, strategies that…”
    Get full text
    Journal Article
  5. 5

    Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies by Whitlock, Gary, Lewington, Sarah, Sherliker, Paul, Clarke, Robert, Emberson, Jonathan, Halsey, Jim, Qizilbash, Nawab, Collins, Rory, Peto, Richard

    Published in The Lancet (British edition) (2009)
    “…Summary Background The main associations of body-mass index (BMI) with overall and cause-specific mortality can best be assessed by long-term prospective…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Mutations in the PCSK9 gene in Norwegian subjects with autosomal dominant hypercholesterolemia by Leren, TP

    Published in Clinical genetics (01-05-2004)
    “…Proprotein convertase subtilisin/kexin type 9 (PCSK9) is at a locus for autosomal dominant hypercholesterolemia, and recent data indicate that the PCSK9 gene…”
    Get full text
    Journal Article
  8. 8

    Effect of mutations in the PCSK9 gene on the cell surface LDL receptors by Cameron, Jamie, Holla, Øystein L., Ranheim, Trine, Kulseth, Mari Ann, Berge, Knut Erik, Leren, Trond P.

    Published in Human molecular genetics (01-05-2006)
    “…The proprotein convertase subtilisin/kexin type 9 (PCSK9) gene is involved in the post-transcriptional regulation of the low-density lipoprotein (LDL)…”
    Get full text
    Journal Article
  9. 9

    Risk prediction of ventricular arrhythmias and myocardial function in Lamin A/C mutation positive subjects by Hasselberg, Nina E, Edvardsen, Thor, Petri, Helle, Berge, Knut E, Leren, Trond P, Bundgaard, Henning, Haugaa, Kristina H

    Published in Europace (London, England) (01-04-2014)
    “…Mutations in the Lamin A/C gene may cause atrioventricular block, supraventricular arrhythmias, ventricular arrhythmias (VA), and dilated cardiomyopathy. We…”
    Get full text
    Journal Article
  10. 10

    PCSK9 acts as a chaperone for the LDL receptor in the endoplasmic reticulum by Strøm, Thea Bismo, Tveten, Kristian, Leren, Trond P

    Published in Biochemical journal (01-01-2014)
    “…PCSK9 (proprotein convertase subtilisin/kexin type 9) binds to the LDLR (low-density lipoprotein receptor) at the cell surface and disrupts recycling of the…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13

    The unique role of proprotein convertase subtilisin/kexin 9 in cholesterol homeostasis by Mousavi, S. A., Berge, K. E., Leren, T. P.

    Published in Journal of internal medicine (01-12-2009)
    “… The LDL receptor (LDLR) plays an essential role in the regulation of plasma (LDL) cholesterol concentrations by virtue of its ability to clear plasma LDL…”
    Get full text
    Journal Article
  14. 14

    The risk of various types of cardiovascular diseases in mutation positive familial hypercholesterolemia; a review by Hovland, Anders, Mundal, Liv J, Veierød, Marit B, Holven, Kirsten B, Bogsrud, Martin Prøven, Tell, Grethe S, Leren, Trond P, Retterstøl, Kjetil

    Published in Frontiers in genetics (06-12-2022)
    “…Familial hypercholesterolemia (FH) is a common, inherited disease characterized by high levels of low-density lipoprotein Cholesterol (LDL-C) from birth. Any…”
    Get full text
    Journal Article
  15. 15

    Subjects with molecularly defined familial hypercholesterolemia or familial defective apoB-100 are not being adequately treated by Leren, Trond P, Berge, Knut Erik

    Published in PloS one (18-02-2011)
    “…To study whether subjects with a molecular genetic diagnosis of familial hypercholesterolemia (FH) or familial defective apoB-100 (FDB) are being adequately…”
    Get full text
    Journal Article
  16. 16

    PCSK9-mediated degradation of the LDL receptor generates a 17 kDa C-terminal LDL receptor fragment by Tveten, Kristian, Str⊘m, Thea Bismo, Berge, Knut Erik, Leren, Trond P.

    Published in Journal of lipid research (01-06-2013)
    “…Proprotein convertase subtilisin/kexin type 9 (PCSK9) binds to the LDL receptor (LDLR) at the cell surface and reroutes the internalized LDLR to intracellular…”
    Get full text
    Journal Article
  17. 17

    Left ventricular mechanical dispersion by tissue Doppler imaging: a novel approach for identifying high-risk individuals with long QT syndrome by Haugaa, Kristina Hermann, Edvardsen, Thor, Leren, Trond P., Gran, Jon Michael, Smiseth, Otto A., Amlie, Jan P.

    Published in European heart journal (01-02-2009)
    “…Aims The aim of this study was to investigate whether prolonged and dispersed myocardial contraction duration assessed by tissue Doppler imaging (TDI) may…”
    Get full text
    Journal Article
  18. 18

    Role of the C-terminal domain of PCSK9 in degradation of the LDL receptors by Holla, Øystein L., Cameron, Jamie, Tveten, Kristian, Str⊘m, Thea Bismo, Berge, Knut Erik, Laerdahl, Jon K., Leren, Trond P.

    Published in Journal of lipid research (01-10-2011)
    “…Proprotein convertase subtilisin/kexin type 9 (PCSK9) binds to the low density lipoprotein receptor (LDLR) at the cell surface and disrupts the normal…”
    Get full text
    Journal Article
  19. 19

    Missense Mutations in the PCSK9 Gene Are Associated With Hypocholesterolemia and Possibly Increased Response to Statin Therapy by Berge, Knut Erik, Ose, Leiv, Leren, Trond P

    “…OBJECTIVE—The proprotein convertase subtilisin/kexin type 9 (PCSK9) gene encodes a proprotein convertase that causes degradation of cell surface low-density…”
    Get full text
    Journal Article
  20. 20

    Cascade genetic screening for familial hypercholesterolemia by Leren, TP

    Published in Clinical genetics (01-12-2004)
    “…Familial hypercholesterolemia (FH) is caused by a mutation in the low‐density lipoprotein receptor gene and is characterized by hypercholesterolemia,…”
    Get full text
    Journal Article